Glioblastoma multiforme: Enhancing survival and quality of life

Clinical Journal of Oncology Nursing

Volumn 15, Issue 3, 2011, Pages 291-297

  Davis, Mary Elizabeth ^a   Stoiber, Ann Marie Mulligan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DACARBAZINE; DRUG DERIVATIVE; TEMOZOLOMIDE;

ARTICLE; GLIOBLASTOMA; HUMAN; MORTALITY; NURSING; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIOTHERAPY; SEIZURE; TUMOR RECURRENCE; UNITED STATES; VENOUS THROMBOEMBOLISM;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; DACARBAZINE; GLIOBLASTOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY; SEIZURES; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 79957901908     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/11.CJON.291-297     Document Type: Article

References (36)

1. Barsevick, A.M., Newhall, T., & Brown, S. (2008). Management of cancer-related fatigue. Clinical Journal of Oncology Nursing, 12(Suppl.), 21-25. doi: 10.1188/08.CJON.S2.21-25
2. Batchelor, T.T., & Byrne, T.N. (2006). Supportive care of brain tumor patients. Hematology/Oncology Clinics of North America, 20, 1337-1361. doi: 10.1016/j.hoc.2006.09.013
3. Booth, C.M., Clemons, M., Dranitsaris, G., Joy, A., Young, S., Callaghan, W., Petrella, T. (2007). Chemotherapy-induced nausea and vomiting in breast cancer patients: A prospective observational study. Journal of Supportive Oncology, 5, 374-380.
4. Brandes, A.A., Tosoni, A., Franceschi, E., Reni, M., Gatta, G., & Vecht, C. (2008). Glioblastoma in adults. Critical Reviews in Oncology/Hematology, 67, 139-152. doi: 10.1016/j.critrevonc.2008.02.005
5. Caruso, G., Raudino, G., Caffo, M., Alafaci, C., Granata, F., Lucerna, S., Tomasello, F. (2010). Nantotechnology platforms in diagnosis and treatment of primary brain tumors. Recent Patents on Nanotechnology, 4, 119-124. doi: 10.2174/187221010791208786
6. Central Brain Tumor Registry of the United States. (2011). Statistical report: Primary brain tumors in the United States (2010-2011 report). Retrieved from http://www.soc-neuro-onc.org/en/art/53
7. Chamberlain, M. (2009). Adult glioblastoma: Evolving evidence for best treatment strategies. Retrieved from http://www.gliomaed.com/programs.asp?ProductID=37&ence
8. Chinot, O.L., Barrié, M., Fuentes, S., Eudes, N., Lancelot, S., Metellus, P., Figarella-Branger, D. (2007). Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. Journal of Clinical Oncology, 25, 1470-1475. doi: 10.1200/JCO.2006.07.4807
9. Crinière, E., Kaloshi, G., Laigle-Donadey, F., Lejeune, J., Auger, N., Benouaich-Amiel, A., Sanson, M. (2007). MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. Journal of Neuro-Oncology, 83, 173-179. doi: 10.1007/s11060-006-9320-0
10. Earnest, F., Baker, H.L., Kispert, D.B., & Laws, E.R. (1985). Magnetic resonance imaging vs. computed tomography: Advantages and disadvantages. Clinical Neurosurgery, 32, 540-573.
11. Eisenson, N. (2007). Management of thrombosis in a neuro-oncology patient. Oncology Nursing Forum, 34, 777-782. doi: 10.1188/07.ONF.777-782
12. Fox, S.W., Mitchell, S.A., & Booth-Jones, M. (2006). Cognitive impairment in patients with brain tumors: Assessment and intervention in the clinic setting. Clinical Journal of Oncology Nursing, 10, 169-176. doi: 10.1188/06.CJON.169-176
13. ® (bevacizumab). Prescribing information. South San Francisco, CA: Author.
14. Halkett, G.K., Lobb, E.A., Oldham, L., & Nowak, A.K. (2010). The information and support needs of patients diagnosed with high grade glioma. Patient Education and Counseling, 79, 112-119.
15. Hegi, M.E., Diserens, A.C., Gorlia, T., Hamou, M.F., de Tribolet, N., Weller, M., Stupp, R. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine, 352, 997-1003. doi: 10.1056/NEJMoa043331
16. Honea, N.J., Brintnall, R., Given, B., Sherwood, P., Colao, D.B., Somers, S.C., & Northouse, L.L. (2008). Putting Evidence Into Practice: Nursing assessment and interventions to reduce family caregiver strain and burden. Clinical Journal of Oncology Nursing, 12, 507-516. doi: 10.1188/08.CJON.507-516
17. Janda, M., Steginga, S., Dunn, J., Langbecker, D., Walker, D., & Eakin, E. (2008). Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Education and Counseling, 71, 251-258.
18. Kargiotis, O., Markoula, S., & Kyritsis, A.O. (2011). Epilepsy in the cancer patient. Cancer Chemotherapy and Pharmacology, 67, 489-501. doi: 10.1007/s00280-011-1569-0
19. Lee, S.M., Thatcher, N., Crowther, D., & Margison, G.P. (1994). Inactivation of O6-alkylguanine-DNA alkytransferase in human peripheral blood mononuclear cells by temozolomide. British Journal of Cancer, 69, 452-456. doi: 10.1038/bjc.1994.82
20. Lexi-Comp, Inc. (2011). Lexicomp online. Retrieved from http://www.lexi.com/institutions/products/online
21. Lobera, A. (2009). Imaging in glioblastoma multiforme. Retrieved from http://emedicine.medscape.com/article/340870
22. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K. (Eds.). (2007). WHO classification of tumours of the central nervous system. Lyon, France: IARC.
23. Marras, L.C., Geerts, W.H., & Perry, J.R. (2000). The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer, 89, 640-646. doi: 10.1002/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E
24. Mayer, R., & Sminia, P. (2008). Reirradiation tolerance of the human brain. International Journal of Radiation Oncology, Biology, Physics, 70, 1350-1360. doi: 10.1016/j.ijrobp.2007.08.015
25. ® (temozolomide). Prescribing information. Whitehouse Station, NJ: Author.
26. National Comprehensive Cancer Network. (2010). NCCN Clinical Practice Guidelines in Oncology™: Central nervous system cancer [v.1.2010]. Retrieved from http://www.nccn.org/professionals/physician_gls/PDF/cns.pdf
27. Navari, R.M. (2003). Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting-Two new agents. Journal of Supportive Oncology, 1, 89-103.
28. Newton, N.B. (2008). Glioblastoma multiforme. Current Treatment Options in Neurology, 10, 285-294. doi: 10.1007/s11940-008-0031-z
29. Nolan, C., & Gavrilovic, I.T. (2010). Pearls: Primary brain tumors. Seminars in Neurology, 30, 5-9. doi: 10.1055/s-0029-1244989
30. Oldervoll, L.M., Kaasa, S., Knobel, H., & Loge, J.H. (2003). Exercise reduces fatigue in chronic fatigued Hodgkins disease survivors-Results from a pilot study. European Journal of Cancer, 39, 57-63. doi: 10.1016/S0959-8049(02)00483-5
31. Porock, D., Kristjanson, L.J., Tinnelly, K., Duke, T., & Blight, J. (2000). An exercise intervention for advanced cancer patients experiencing fatigue: A pilot study. Journal of Palliative Care, 16(3), 30-36.
32. Smith, K.C. (2010). The management of seizures in brain tumor patients. Journal of Neuroscience Nursing, 42, 28-37.
33. Sperling, M.R., & Ko, J. (2006). Seizures and brain tumors. Seminars in Oncology, 33, 333-341. doi: 10.1053/j.seminoncol.2006.03.009
34. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., irimanoff, R.O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New England Journal of Medicine, 10, 987-996. doi: 10.1056/NEJMoa043330
35. Van Meir, E.G., Hadjipanayis, C.G., Norden, A.D., Shu, H.K., Wen, P.Y., & Olson, J.J. (2010). Exciting new advances in neuro-oncology: The avenue to a cure for malignant glioma. CA: A Cancer Journal for Clinicians, 60, 166-193. doi: 10.3322/caac.20069
36. Wen, P.Y., & Kesari, S. (2008). Malignant gliomas in adults. New England Journal of Medicine, 359, 492-507. doi: 10.1056/NEJMra0708126